0001104659-21-119309.txt : 20210924
0001104659-21-119309.hdr.sgml : 20210924
20210924162111
ACCESSION NUMBER: 0001104659-21-119309
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210923
FILED AS OF DATE: 20210924
DATE AS OF CHANGE: 20210924
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LAPOINTE ANTHONY GREGG
CENTRAL INDEX KEY: 0001331860
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14778
FILM NUMBER: 211277570
MAIL ADDRESS:
STREET 1: PO BOX 83216
CITY: GAITHERSBURG
STATE: MD
ZIP: 20883-3216
FORMER NAME:
FORMER CONFORMED NAME: Lapointe Gregg Anthony
DATE OF NAME CHANGE: 20050630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SOLIGENIX, INC.
CENTRAL INDEX KEY: 0000812796
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 411505029
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
BUSINESS PHONE: 609-538-8200
MAIL ADDRESS:
STREET 1: 29 EMMONS DRIVE
STREET 2: SUITE B-10
CITY: PRINCETON
STATE: NJ
ZIP: 08540
FORMER COMPANY:
FORMER CONFORMED NAME: DOR BIOPHARMA INC
DATE OF NAME CHANGE: 20020329
FORMER COMPANY:
FORMER CONFORMED NAME: ENDOREX CORP
DATE OF NAME CHANGE: 19960916
FORMER COMPANY:
FORMER CONFORMED NAME: IMMUNOTHERAPEUTICS INC
DATE OF NAME CHANGE: 19920703
4
1
tm2128426-2_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-09-23
0
0000812796
SOLIGENIX, INC.
SNGX
0001331860
LAPOINTE ANTHONY GREGG
29 EMMONS DRIVE, SUITE B-10
PRINCETON
NJ
08540
1
0
0
0
Stock Option (Right to Buy)
1.03
2021-09-23
4
A
0
29126
0
A
2031-09-22
Common Stock
29126
29126
D
The stock option vests ratably on each of December 23, 2021, March 23, 2022, June 23, 2022 and September 23, 2022.
/s/ Gregg A. Lapointe
2021-09-24